• Explore /
  • Poster
  • / Targeting innate immunity with BXCL701 in combination with pembrolizumab in patients with advanced solid cancers: Phase 2 basket study.

Targeting innate immunity with BXCL701 in combination with pembrolizumab in patients with advanced solid cancers: Phase 2 basket study.

Abstract Video & Slides Poster

Authors

null

Ozgur Karakuzu

The University of Texas MD Anderson Cancer Center, Houston, TX

Ozgur Karakuzu , Apostolia Maria Tsimberidou , Veronica R. Holley , Abha Adat , Sapna Pradyuman Patel , Anil K. Sood , Anthony Paul Conley , Gabriele E Urschel , Diane I. Healey , Vincent O'Neill , Filip Janku

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics—Immunotherapy

Sub Track

New Targets and New Technologies (IO)

Clinical Trial Registration Number

NCT04171219

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 2558)

DOI

10.1200/JCO.2021.39.15_suppl.2558

Abstract #

2558

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Manish Sharma

First Author: Andreea Varga

First Author: Susanna Varkey Ulahannan

First Author: Timothy Jay Price